BPC-157 has been shown to accelerate the healing of muscles, tendons, ligaments and inflammatory bowel disorders such as ulcers, leaky gut, and Crohn’s disease.
BPC-157 is a penta-decapeptide composed of 15 amino acids. It is a partial sequence of the body protection compound (BPC) that was discovered in and isolated from human gastric juice. Animal studies have shown it to accelerate the healing of many different wounds, including muscle, tendon and damaged ligaments. Additionally, BPC 157 has shown to protect organs and aids in the prevention of gastric ulcers. BPC-157 acts systemically in the digestive tract to combat leaky gut, IBS, gastro-intestinal cramps, and Crohn’s disease. This peptide has been known to exhibit analgesic characteristics. Research has shown its ability to help skin burns heal at a faster rate by increasing blood flow to damaged tissues. BPC-157 significantly accelerates reticulin and collagen formation as well as angiogenesis together with stimulation of macrophages and fibroblasts infiltration representing a potential therapeutic tool in wound healing management.
Research
There are several scientific studies related to TB-500 (Thymosin Beta-4) peptides, including the following:
Thymosin Beta-4 Accelerates Wound Healing
Published in the Annals of the New York Academy of Sciences in 2004, this study investigates the role of Thymosin Beta-4 in accelerating wound healing, particularly in the cornea.
Thymosin β4: multiple functions in repair
Published in the Journal of Cellular Biochemistry in 2011, this review article discusses the various functions of Thymosin β4 in tissue repair processes.
Thymosin beta-4 is cardioprotective after myocardial infarction
Published in the Annals of the New York Academy of Sciences in 2007, this study explores the cardioprotective effects of Thymosin beta-4 after myocardial infarction.
Thymosin beta 4: a key factor in wound healing and fibrosis
Published in the BioFactors journal in 2011, this review article discusses the role of Thymosin beta 4 in wound healing and fibrosis.
Thymosin beta-4 inhibits corneal epithelial cell apoptosis after ethanol exposure in vitro
Published in the Investigative Ophthalmology & Visual Science journal in 2004, this study examines the potential of Thymosin beta-4 in inhibiting corneal epithelial cell apoptosis after ethanol exposure.
These studies provide insights into the potential therapeutic applications and mechanisms of action of TB-500 peptides in various physiological processes in animals, including wound healing, cardiac protection, and tissue repair.
Reviews
There are no reviews yet.